Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mHRME for Anal HSIL Diagnosis in HIV
NCT04563754Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2019
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Baylor College of Medicine. Primary endpoints: Sensitivity at 1 day, Specificity at 1 day and 2 more. Started Jul 2019; status: completed.
Beyond the preview
Go deeper on NCT04563754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04563754.